The chief financial officer of Wyeth expressed optimism on February 9th that tens of thousands of lawsuits by users of the recalled "fen-phen" diet drugs may be settled during the next year or two.

Wyeth announced today that the jury in the case of Bonnie Weston v. Wyeth in Missouri Circuit Court found in favor of Wyeth.

The FDA warned consumers Friday not to use two unapproved Brazilian diet pills because testing has revealed they may contain tranquilizers, antidepressants and stimulants.

An Auckland man and his company have been ordered to refund $175,000 after falsely claiming a tablet could "melt away" fat and cellulite. However, the refunds, which could benefit thousands of customers who bought Celluslim tablets, are on hold pending an appeal.

Wyeth announced today that the jury in the cases of Brigitte DeMonja v. Wyeth and Dorothy Parkin v. Wyeth in the Philadelphia Court of Common Pleas found in favor of the Company in the Parkin case. In the DeMonja case, the jury assessed total damages in the amount of $88,000. Wyeth announced that it intends to appeal this verdict. Three other plaintiffs were originally part of this trial group. Those plaintiffs all voluntarily chose to dismiss their cases before trial.

The trial began on October 17, 2005 before The Honorable Matthew Carrafiello. The plaintiffs alleged heart valve injury from the use of the diet drugs Pondimin, a drug once marketed by Wyeth.